The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Defective Regulatory T Cells In Patients with Severe Drug Eruptions: Timing of the Dysfunction Is Associated with the Pathological Phenotype and Outcome
Abstract
Toxic epidermal necrolysis (TEN) and drug-induced hypersensitivity syndrome (DIHS) represent two ends of a spectrum of severe drug eruptions: DIHS is unique in that severe epidermal damage seen in TEN is absent, sequential reactivations of herpesviruses occur, and autoimmunity often ensues. To investigate whether changes in regulatory T (Treg) cell function would contribute to variability in the clinical manifestations, we examined the frequency, phenotype, and function of Treg cells both during the acute stage and again long after clinical resolution of both diseases. Dramatic expansions of functional Treg cells were found in the acute stage of DIHS. In contrast, Treg function was profoundly impaired in TEN, although present in normal frequency. Skin homing addressins were more preferentially expressed on Treg cells in DIHS than in TEN. Indeed, Treg cells were more abundantly present in the skin lesions of DIHS. Surprisingly, Treg cells contracted upon resolution of DIHS became functionally deficient, whereas their functional defects in TEN were restored upon recovery. These findings indicate that a transitory impairment in their function during the acute stage of TEN may be related to severe epidermal damage, while a gradual loss of their function after resolution of DIHS may increase the risk of subsequently developing autoimmune disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Bastuji‐Garin, S. (1993) · Archives of Dermatology · doi:10.1001/archderm.129.1.92 · Cited by 1,697
Severe Adverse Cutaneous Reactions to Drugs
Roujeau, J. C., & Stern, R. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311906 · Cited by 1,571
Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells
Wang, J., Ioan‐Facsinay, A., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M. (2007) · European Journal of Immunology · doi:10.1002/eji.200636435 · Cited by 1,011
Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products
Lien, E., Sellati, T. J., Yoshimura, A., Flo, T. H., Rawadi, G., Finberg, R. W., Carroll, J. D., Espevik, T., Ingalls, R. R., Radolf, J. D., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33419 · Cited by 918
Iellem, A., Mariani, M., Lang, R., Recalde, H., Panina-Bordignon, P., Sinigaglia, F., & D'Ambrosio, D. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.847 · Cited by 914
Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K. (2007) · International Immunology · doi:10.1093/intimm/dxm014 · Cited by 872 · cited 1×
“Nevertheless, it was also possible that the increased frequency of Treg cells observed in DIHS merely reflects the overall status of activation of T cells, because recent studies on human Treg cells have demonstrated that TCR stimulation alone with anti-CD3 and anti-CD28 induces Foxp3 expression without acquisition of…”
BackgroundThe chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
Campbell, J. J., Haraldsen, G., Pan, J., Rottman, J., Qin, S., Ponath, P., Andrew, D. P., Warnke, R., Ruffing, N., Kassam, N., et al. (1999) · Nature · doi:10.1038/23495 · Cited by 841
Tran, D. Q., Ramsey, H., & Shevach, E. M. (2007) · Blood · doi:10.1182/blood-2007-06-094656 · Cited by 743
SHELBURNE, S. A., HAMILL, R. J., RODRIGUEZ-BARRADAS, M. C., GREENBERG, S. B., ATMAR, R. L., MUSHER, D. M., GATHE, J. C., VISNEGARWALA, F., & TRAUTNER, B. W. (2002) · Medicine · doi:10.1097/00005792-200205000-00005 · Cited by 654
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin‐Su, K., Ten, S., Sanz, M. M., Exley, M. A., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13605 · Cited by 640
Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis
Kurt-Jones, E. A., Chan, M., Zhou, S., Wang, J., Reed, G., Bronson, R., Arnold, M. M., Knipe, D. M., & Finberg, R. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308057100 · Cited by 611
Sugiyama, H., Gyulai, R., Toichi, E., Garaczi, E., Shimada, S., Stevens, S. R., McCormick, T. S., & Cooper, K. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.164 · Cited by 570
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin-Su, K., Ten, S., Sanz, M., Exley, M., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213605 · Cited by 566
Shiohara, T., Iijima, M., Ikezawa, Z., & Hashimoto, K. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07807.x · Cited by 523
Self-citationActivated CD4+CD25+ T cells selectively kill B lymphocytes
Zhao, D.-M., Thornton, A. M., DiPaolo, R. J., & Shevach, E. M. (2006) · Blood · doi:10.1182/blood-2005-11-4502 · Cited by 506
Shiohara, T., Inaoka, M., & Kano, Y. (2006) · Allergology International · doi:10.2332/allergolint.55.1 · Cited by 485
Self-citationThe immune paradox of sarcoidosis and regulatory T cells
Miyara, M., Amoura, Z., Parizot, C., Badoual, C., Dorgham, K., Trad, S., Kambouchner, M., Valeyre, D., Chapelon-Abric, C., Debré, P., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050648 · Cited by 450
Anticonvulsant Hypersensitivity Syndrome
Vittorio, C. C. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.21.2285 · Cited by 436
Balandina, A., Lécart, S., Dartevelle, P., Saoudi, A., & Berrih-Aknin, S. (2005) · Blood · doi:10.1182/blood-2003-11-3900 · Cited by 429
Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells
Nassif, A., Bensussan, A., Boumsell, L., Deniaud, A., Moslehi, H., Wolkenstein, P., Bagot, M., & Roujeau, J.-C. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.07.047 · Cited by 412
Lewkowich, I. P., Herman, N. S., Schleifer, K. W., Dance, M. P., Chen, B. L., Dienger, K. M., Sproles, A. A., Shah, J. S., Köhl, J., Belkaid, Y., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051506 · Cited by 402
Prevention of toxic epidermal necrolysis by regulatory T cells
Azukizawa, H., Sano, S., Kosaka, H., Sumikawa, Y., & Itami, S. (2005) · European Journal of Immunology · doi:10.1002/eji.200425773 · Cited by 380
T-cell involvement in drug-induced acute generalized exanthematous pustulosis
Britschgi, M., Steiner, U. C., Schmid, S., Depta, J. P. H., Senti, G., Bircher, A., Burkhart, C., Yawalkar, N., & Pichler, W. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12118 · Cited by 360
Suzuki, Y., Inagi, R., Aono, T., Yamanishi, K., & Shiohara, T. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.9.1108 · Cited by 349
Self-citationHirahara, K., Liu, L., Clark, R. A., Yamanaka, K.-I., Fuhlbrigge, R. C., & Kupper, T. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4488 · Cited by 291
Kano, Y., Hirahara, K., Mitsuyama, Y., Takahashi, R., & Shiohara, T. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01553.x · Cited by 276
Self-citationKano, Y., Inaoka, M., & Shiohara, T. (2004) · Archives of Dermatology · doi:10.1001/archderm.140.2.183 · Cited by 246
Self-citationToll-like receptors on regulatory T cells: expanding immune regulation
Sutmuller, R. P. M., Morgan, M. E., Netea, M. G., Grauer, O., & Adema, G. J. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.06.005 · Cited by 205
Clark, R. A., & Kupper, T. S. (2007) · Blood · doi:10.1182/blood-2006-02-002873 · Cited by 179
Le Cleach, L., Delaire, S., Boumsell, L., Bagot, M., Bourgault-Villada, I., Bensussan, A., & Roujeau, J. C. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2000.01119.x · Cited by 172
Sekine, N. (2001) · JAMA · doi:10.1001/jama.285.9.1153 · Cited by 114
Azukizawa, H., Kosaka, H., Sano, S., Heath, W. R., Takahashi, I., Gao, X., Sumikawa, Y., Okabe, M., Yoshikawa, K., & Itami, S. (2003) · European Journal of Immunology · doi:10.1002/eji.200323630 · Cited by 102
Drug Hypersensitivity Reactions: Classification and Relationship to T-Cell Activation
Pichler, W. J. (2007) · KARGER eBooks · doi:10.1159/000104199 · Cited by 94
Chiou, C.-C., Chung, W., Chung, W., Yang, L., & Hong, H. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.03.057 · Cited by 90
Vanasek, T. L., Nandiwada, S. L., Jenkins, M. K., & Mueller, D. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5880 · Cited by 34
Takahashi, R., Mizukawa, Y., Yamazaki, Y., Hayakawa, K., Hayakawa, J., Kudo, A., & Shiohara, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5769 · Cited by 18
Self-citationAnimal models of toxic epidermal necrolysis
Azukizawa, H. (2011) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2010.01173.x · Cited by 13
Cited by
Severe cutaneous adverse reactions to drugs
Duong, T. A., Valeyrie-Allanore, L., Wolkenstein, P., & Chosidow, O. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30378-6 · Cited by 445
Praga, M., Sevillano, A., Auñón, P., & González, E. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu326 · Cited by 147
Metadata
- Authors
- Takahashi, R., Kano, Y., Yamazaki, Y., Kimishima, M., Mizukawa, Y., & Shiohara, T.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-06
- Volume
- 182
- Issue
- 12
- Pages
- 8071-8079
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1513629354
- Cited by
- 276
- References
- 39
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.